Globus Medical Inc (NYSE:GMED)

23.96
Delayed Data
As of Mar 03
 -0.41 / -1.68%
Today’s Change
17.45
Today|||52-Week Range
27.14
+0.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$2.3B

Company Description

Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in-patients with spine disorders. It develops products that assist surgeons in effectively treating their patients, respond to evolving surgeon needs and address new treatment options. The company's products are classified into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products are uses in cervical, thoracolumbar, sacral, and interbody, corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. The Disruptive Technologies are those that represent a significant shift in the treatment of spine disorders by allowing for novel surgical procedures, improvements to existing surgical procedures, the treatment of spine disorders by new physician specialties, and surgical intervention earlier in the continuum of care. Globus Medical was founded by David Paul in March 2003 and is headquartered in Audubon, PA.

Contact Information

Globus Medical, Inc.
Valley Forge Business Center
Audubon Pennsylvania 19403
P:(610) 930-1800
Investor Relations:

Employees

Shareholders

Other institutional47.66%
Mutual fund holders40.51%
Individual stakeholders27.29%

Top Executives

David C. PaulChairman & Chief Executive Officer
David M. DemskiPresident, COO, CFO & Director
David D. DavidarDirector & Senior Vice President-Operations
Kevin CarougeSenior Vice President-Corporate Development
Ole StoklundVice President-International

To view my watchlist

Not a member yet?

Sign up now for a free account